Alibaba
BABA
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
Apple
AAPL
US Stock MarketDetailed Quotes
XENE Xenon Pharmaceuticals
- 38.910
- -0.350-0.89%
Close Feb 14 16:00 ET
- 40.190
- +1.280+3.29%
Pre 06:50 ET
2.97BMarket Cap-13.85P/E (TTM)
39.840High38.460Low411.31KVolume39.340Open39.260Pre Close16.00MTurnover0.58%Turnover RatioLossP/E (Static)76.24MShares50.99052wk High3.72P/B2.74BFloat Cap35.53052wk Low--Dividend TTM70.47MShs Float50.990Historical High--Div YieldTTM3.52%Amplitude2.100Historical Low38.905Avg Price1Lot Size
About Xenon Pharmaceuticals Company
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
Company Profile
SymbolXENE
Company NameXenon Pharmaceuticals
Listing DateNov 5, 2014
Issue Price9.00
Founded1996
CEOMr. Ian C. Mortimer
MarketNASDAQ
Employees259
Fiscal Year Ends12-31
Address3650 Gilmore Way,Suite 200
CityBurnaby
ProvinceBritish Columbia
CountryCanada
Zip CodeV5G 4W8
Phone1-604-484-3300
Websitehttp://www.xenon-pharma.com
Company Executives
- Name
- Position
- Salary
- Ian C. Mortimer
- Director, Chief Executive Officer and President
- 9.77M
- Christopher John Kenney
- Chief Medical Officer
- 3.58M
- Sherry Aulin
- Chief Financial Officer and Principal Accounting Officer
- 3.52M
- Andrea DiFabio
- Chief Legal Officer and Corporate Secretary
- --
- James R. Empfield
- Executive Vice President, Drug Discovery
- --
- Dr. Robin Sherrington, PhD
- Executive Vice President, Strategy and Innovation
- 2.37M
- Dr. Gillian M. Cannon, PhD
- Independent Director
- 770.91K
- Steven Gannon
- Independent Director
- 561.42K
- Justin David Gover
- Independent Director
- 770.91K
- Gary Patou, M.D.
- Independent Director
- 560.09K
- Dawn A. Svoronos
- Lead Independent Director
- 588.37K
- Patrick C. Machado, J.D.
- Independent Director
- 559.58K
- Dr. Elizabeth A. Garofalo, M.D.
- Independent Director
- 548.57K
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.